Carl Zeiss Meditec Delivers Key Technological Advances in Optical Coherence Tomography
DUBLIN, Calif.--(BUSINESS WIRE)--Carl Zeiss Meditec, a leader in ophthalmic devices and surgical systems, announced today that two new optical coherence tomography (OCT) applications will be
Read Full Article
Related Articles
- Assessment of macular function by microperimetry in unilateral resolved central serous chorioretinopathy also categorized in Ophthalmology
- Correlation between microaneurysm closure rate and reduction in macular thickness following laser photocoagulation of diabetic macular edema also categorized in Ophthalmology
- Automatic retinal blood flow calculation using spectral domain optical coherence tomography also categorized in Ophthalmology
- GlucoLight Corporation Raises Second Tranche of ''c'' Round Financing also published in businesswire.com
- Evaluation of peripapillary detachment in pathologic myopia with en face optical coherence tomography also categorized in Ophthalmology
- GlucoLight Corporation Raises Second Tranche of “c” Round Financing also published in businesswire.com
- OCTANe Foundation for Innovation Grants $20,000 Innovation Award also published in businesswire.com
- Change of foveal and perifoveal thickness measured by OCT after phacoemulsification and IOL implantation also categorized in Ophthalmology
- In vivo measurements of macular and nerve fibre layer thickness in retinal arterial occlusion also categorized in Ophthalmology
- Assessment of macular retinal thickness and volume in normal eyes and highly myopic eyes with third-generation optical coherence tomography also categorized in Ophthalmology
Login to comment.